Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive valid, exclusive mass tort cases. Our program is built on a ‘Medical-First’ ...
ALLENTOWN, PA, UNITED STATES, February 12, 2026 /EINPresswire.com/ — Mohr Marketing, LLC announced today the launch of its “Medical-First” Compliance Program, a ...
-- Global pharmaceutical company Pfizer Inc. (NYSE: PFE), manufacturer of contraceptive injection Depo-Provera (DMPA), is facing a Multidistrict Litigation (MDL No. 3140) in the USA being brought on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results